Physician profile
Breenecia Scott
NPI 1306324769
$1,891.40
in general payments reported to CMS, 2019-2025
21 companies · $17.67 in 2025
The $17.67 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $215 · 2022: $1,297 · 2023: $362 · 2025: $17.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $402.22 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $200.80 | 2021-2023 | Rexulti, Abilify Maintena |
| Alkermes, INC. | $199.27 | 2022-2023 | Lybalvi |
| Vanda Pharmaceuticals INC. | $180.74 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $152.56 | 2022-2023 | |
| Lundbeck LLC | $126.77 | 2022-2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $93.49 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $77.96 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.58 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $63.32 | 2022-2023 | Ingrezza |
| Corium, LLC | $62.23 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $55.06 | 2022 | |
| Supernus Pharmaceuticals, INC. | $47.08 | 2022 | |
| Axsome Therapeutics, INC. | $38.46 | 2022-2023 | Auvelity |
| Adlon Therapeutics L.P. | $21.13 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $19.18 | 2021 | |
| Glaxosmithkline, LLC. | $17.67 | 2025 | Bexsero |
| Novo Nordisk INC | $17.10 | 2023 | Wegovy |
| Oxford Immunotec USA INC | $15.04 | 2021 | |
| Theratechnologies INC. | $14.00 | 2021 | |
| Tris Pharma INC | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breenecia Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.